Barold S Serge, Kucher Andreas
Department of Medicine, University of Rochester School of Medicine and Dentistry, Rochester, NY, United States of America.
BIOTRONIK, Berlin, Germany.
J Electrocardiol. 2019 Jul-Aug;55:111-115. doi: 10.1016/j.jelectrocard.2019.05.010. Epub 2019 May 21.
We report on three patients with heart failure and left bundle branch block who received a BIOTRONIK implantable defibrillator with resynchronization therapy which manifested loss of resynchronization only at a specific time of the night. Desynchronization was sudden and repeatedly initiated by the daily automatic right ventricular pacing threshold test. Loss of resynchronization occurred after switching back from the temporary test mode to the permanent biventricular pacing mode due to the reactivation of the left ventricular (LV) control of the timing cycles. LV sensed events prevented the emission of an LV paced event by virtue of a realigned LV upper rate interval, thus inhibiting LV pacing.
我们报告了三名患有心力衰竭和左束支传导阻滞的患者,他们接受了带有再同步治疗功能的百多力植入式除颤器,该除颤器仅在夜间特定时间出现再同步丧失。失同步是突然发生的,并且每天的自动右心室起搏阈值测试会反复引发。由于左心室(LV)对计时周期的控制重新激活,在从临时测试模式切换回永久双心室起搏模式后发生了再同步丧失。左心室感知事件通过重新调整的左心室上限频率间期阻止了左心室起搏事件的发出,从而抑制了左心室起搏。